Gastrointestinal
Biora submits updated IND application for ulcerative colitis drug/device trial
Biora Therapeutics has submitted an updated investigational new drug (IND) application with the US Food and Drug Administration (FDA) for…
Microba signs distribution agreement with Sonic for MetaPanel test
Microba Life Sciences has signed a distribution agreement with Sonic Healthcare through its wholly-owned subsidiary Douglass Hanly Moir Pathology, for…
Motus GI concludes initial assessment of device for upper GI procedures
Motus GI and the Ecuadorian Institute of Digestive Diseases (IECED) have completed the initial clinical assessment of the Pure-Vu Gen…
Canadian colonoscopes market set to exceed $65 million by 2030
March is Colorectal Cancer Awareness Month in Canada, where colorectal cancer is second only to lung cancer as the leading…
Olympus joins biliary stent sector – market predicted to be $1bn by 2030
On February 24th, 2023, Olympus Corporation announced it had agreed to acquire Taewoong Medical, a South Korea-based manufacturer specialising in…
Microba Life Sciences unveils next-generation testing product range
Microba Life Sciences has launched its next-generation testing product range, MetaXplore, under Co-Biome, a new brand. Launched in Australia, the…
Boston Scientific to acquire Apollo Endosurgery for $615m
Boston Scientific has signed a definitive agreement to buy minimally invasive medical device company Apollo Endosurgery in a deal valued…
Beyond biopsy: how noninvasive NASH tests can move the needle
Liver biopsy—a process whereby a small piece of liver tissue is extracted via a needle—is the reigning gold standard to…
